Objective To determine the extent to which cardiovascular therapies are prescribed in
primary care for those with diabetes, compared with those without diabetes. Methods …

What is already known about this subject• Previous cross‐sectional studies have
demonstrated underuse of cardiovascular medicines in the population with diabetes. What …

Purpose Some classes of glucose-lowering medications, including sodium-glucose co-
transporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1-receptor agonists (GLP1 …

Cardiovascular disease is the leading cause of morbidity and mortality among patients with
diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase …

All medications currently approved by the Food and Drug Administration (FDA) for the
treatment of type 2 diabetes mellitus are indicated to improve glycemic control. Since 1995 …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

BACKGROUND: Diabetic patients have a higher rate of recurrent cardiovascular events and
death than nondiabetic individuals. Although partially attributable to lower use of evidence …

Hypertension and lipid disorders in type II diabetes contribute to increased coronary risk, but
optimal drug therapy has not been defined. We investigated primary care physicians choices …

Metformin is, if not contraindicated and if tolerated, usually preferred over other antidiabetic
drugs for the first line treatment of type-2 diabetes. The particular decision on which …

Background In order to influence every day clinical practice professional organisations issue
management guidelines. Cross-sectional surveys are used to evaluate the implementation …